SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: billkirn who wrote (5725)12/3/1998 8:47:00 AM
From: John F Beule  Read Replies (2) of 6136
 
Early detection = early treatment, news should be good for the likes of AGPH:

Calypte Biomedical Corp. (CALY): A new study found that a urine test made by the maker of screening tests can detect exposure to HIV in patients who failed to show exposure to the AIDS virus when their blood was tested. The results could help the company in its bid to persuade the U.S. Food and Drug Administration to let it market the product to screen blood donors who make the 25 to 30 million blood donations collected each year in the U.S. Calypte remained unchanged at 2 1/4.

John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext